Details for New Drug Application (NDA): 216648
✉ Email this page to a colleague
The generic ingredient in MITOMYCIN is mitomycin. There are seven drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the mitomycin profile page.
Summary for 216648
Tradename: | MITOMYCIN |
Applicant: | Gland Pharma Ltd |
Ingredient: | mitomycin |
Patents: | 0 |
Pharmacology for NDA: 216648
Mechanism of Action | Alkylating Activity |
Medical Subject Heading (MeSH) Categories for 216648
Suppliers and Packaging for NDA: 216648
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
MITOMYCIN | mitomycin | INJECTABLE;INJECTION | 216648 | ANDA | Sagent Pharmaceuticals | 25021-252 | 25021-252-51 | 1 VIAL in 1 CARTON (25021-252-51) / 80 mL in 1 VIAL |
MITOMYCIN | mitomycin | INJECTABLE;INJECTION | 216648 | ANDA | Fresenius Kabi USA, LLC | 65219-568 | 65219-568-00 | 1 VIAL, SINGLE-DOSE in 1 CARTON (65219-568-00) / 80 mL in 1 VIAL, SINGLE-DOSE |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 40MG/VIAL | ||||
Approval Date: | Nov 22, 2022 | TE: | AP | RLD: | No |
Complete Access Available with Subscription